Literature DB >> 11952256

Radiofrequency ablation of recurrent cholangiocarcinoma.

Douglas P Slakey1.   

Abstract

Intrahepatic recurrence of cholangiocarcinoma after primary resection has traditionally been considered a contraindication to surgical management. Improvements in ablative technologies such as radiofrequency ablation (RFA) offer the surgeon additional alternatives in the management of selected intrahepatic tumors. We present a case report of a single intrahepatic recurrence of cholangiocarcinoma 12 months after primary resection of extrahepatic cholangiocarcinoma including right lobectomy for intrahepatic extension. The patient received operative treatment and RFA of the intrahepatic lesion. RFA successfully ablated the recurrent tumor, and the patient remains free of detectable disease 10 months later. A review of literature is presented. This is the first known report of the use of RFA for intrahepatic cholangiocarcinoma. In selected cases of primary or recurrent cholangiocarcinoma, RFA may increase the percentage of patients considered surgically treatable.

Entities:  

Mesh:

Year:  2002        PMID: 11952256

Source DB:  PubMed          Journal:  Am Surg        ISSN: 0003-1348            Impact factor:   0.688


  14 in total

Review 1.  Local recurrence after hepatic radiofrequency coagulation: multivariate meta-analysis and review of contributing factors.

Authors:  Stefaan Mulier; Yicheng Ni; Jacques Jamart; Theo Ruers; Guy Marchal; Luc Michel
Journal:  Ann Surg       Date:  2005-08       Impact factor: 12.969

Review 2.  Ablative therapies for intrahepatic cholangiocarcinoma.

Authors:  Junichi Shindoh
Journal:  Hepatobiliary Surg Nutr       Date:  2017-02       Impact factor: 7.293

Review 3.  Surgical treatment for intrahepatic cholangiocarcinoma.

Authors:  Takahiro Uenishi; Takatsugu Yamamoto; Shigekazu Takemura; Shoji Kubo
Journal:  Clin J Gastroenterol       Date:  2014-02-15

Review 4.  Endoscopic Radiofrequency Ablation of the Pancreas.

Authors:  Tarun Rustagi; Ankit Chhoda
Journal:  Dig Dis Sci       Date:  2017-02-03       Impact factor: 3.199

Review 5.  Intraductal radiofrequency ablation for management of malignant biliary obstruction.

Authors:  Tarun Rustagi; Priya A Jamidar
Journal:  Dig Dis Sci       Date:  2014-06-07       Impact factor: 3.199

Review 6.  Cholangiocarcinoma: modern advances in understanding a deadly old disease.

Authors:  Harmeet Malhi; Gregory J Gores
Journal:  J Hepatol       Date:  2006-09-25       Impact factor: 25.083

Review 7.  Transarterial therapies for the treatment of intrahepatic cholangiocarcinoma.

Authors:  Joseph J Zechlinski; William S Rilling
Journal:  Semin Intervent Radiol       Date:  2013-03       Impact factor: 1.513

8.  Radiofrequency ablation for postoperative recurrences of intrahepatic cholangiocarcinoma.

Authors:  Ying Fu; Wei Yang; Wei Wu; Kun Yan; Bao-Cai Xing; Min-Hua Chen
Journal:  Chin J Cancer Res       Date:  2011-12       Impact factor: 5.087

9.  Radiofrequency ablation as a treatment for hilar cholangiocarcinoma.

Authors:  Wei-Jun Fan; Pei-Hong Wu; Liang Zhang; Jin-Hua Huang; Fu-Jun Zhang; Yang-Kui Gu; Ming Zhao; Xiang-Long Huang; Chang-Yu Guo
Journal:  World J Gastroenterol       Date:  2008-07-28       Impact factor: 5.742

10.  Treatment of unresectable cholangiocarcinoma with gemcitabine-based transcatheter arterial chemoembolization (TACE): a single-institution experience.

Authors:  Niraj J Gusani; Fady K Balaa; Jennifer L Steel; David A Geller; J Wallis Marsh; Albert B Zajko; Brian I Carr; T Clark Gamblin
Journal:  J Gastrointest Surg       Date:  2007-09-11       Impact factor: 3.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.